x
|
Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended
September 30, 2017
.
|
¨
|
Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
Delaware
(State or Other Jurisdiction of
Incorporation or Organization) |
77-0312442
(I.R.S. Employer Identification No.)
|
PART I - FINANCIAL INFORMATION
|
|
|
Item 1. Financial Statements
|
||
|
Condensed Consolidated Balance Sheets at September 30, 2017 (unaudited) and December 31, 2016
|
|
|
Unaudited Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2017 and 2016
|
|
|
Unaudited Condensed Consolidated Statement of Stockholders’ Equity for the nine months ended September 30, 2017
|
|
|
Unaudited Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2017 and 2016
|
|
|
Notes to unaudited Condensed Consolidated Financial Statements
|
|
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
||
Item 3. Quantitative and Qualitative Disclosures About Market Risk
|
||
Item 4. Controls and Procedures
|
||
|
|
|
PART II - OTHER INFORMATION
|
|
|
Item 1. Legal Proceedings
|
||
Item 1A. Risk Factors
|
||
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
|
||
Item 3. Defaults Upon Senior Securities
|
||
Item 4. Mine Safety Disclosures
|
||
Item 5. Other Information
|
||
Item 6. Exhibits
|
||
Signatures
|
|
September 30, 2017
|
|
December 31, 2016
|
||||
|
(Unaudited)
|
|
|
||||
ASSETS
|
|
|
|
||||
Current assets:
|
|
|
|
||||
Cash
|
$
|
1,439
|
|
|
$
|
1,140
|
|
Accounts receivable, net
|
1,367
|
|
|
1,635
|
|
||
Prepaid expenses and other current assets
|
767
|
|
|
978
|
|
||
Total current assets
|
3,573
|
|
|
3,753
|
|
||
Property and equipment, net
|
1,339
|
|
|
2,203
|
|
||
Goodwill
|
7,750
|
|
|
9,225
|
|
||
Intangibles, net
|
658
|
|
|
1,309
|
|
||
Other assets
|
10
|
|
|
10
|
|
||
Total assets
|
$
|
13,330
|
|
|
$
|
16,500
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
||||
Current liabilities:
|
|
|
|
||||
Current portion of long-term debt
|
$
|
1,298
|
|
|
$
|
10,660
|
|
Accounts payable
|
202
|
|
|
75
|
|
||
Accrued expenses and other liabilities
|
846
|
|
|
1,165
|
|
||
Accrued dividends
|
56
|
|
|
47
|
|
||
Liability for common stock warrants
|
165
|
|
|
—
|
|
||
Accrued sales taxes and regulatory fees
|
310
|
|
|
395
|
|
||
Total current liabilities
|
2,877
|
|
|
12,342
|
|
||
Long term liabilities:
|
|
|
|
||||
Deferred tax liability
|
—
|
|
|
230
|
|
||
Long term debt, net of current portion
|
490
|
|
|
—
|
|
||
Total long term liabilities
|
490
|
|
|
230
|
|
||
Total liabilities
|
3,367
|
|
|
12,572
|
|
||
Commitments and contingencies (see Note 13)
|
|
|
|
|
|
||
Stockholders’ equity:
|
|
|
|
||||
Preferred stock, Series A-2, convertible; $.0001 par value; $7,500 stated value; 7,500 shares authorized, 32 shares issued and outstanding and liquidation preference of $237 at September 30, 2017 and December 31, 2016
|
100
|
|
|
100
|
|
||
Common stock, $.0001 par value; 150,000,000 shares authorized; 36,782,000 issued and 36,130,000 outstanding at September 30, 2017 and 36,659,000 issued and 36,455,000 outstanding at December 31, 2016
|
4
|
|
|
4
|
|
||
Treasury stock, 652,000 and 204,000 shares at September 30, 2017 and December 31, 2016, respectively
|
(353
|
)
|
|
(219
|
)
|
||
Additional paid-in capital
|
180,656
|
|
|
180,333
|
|
||
Accumulated deficit
|
(170,444
|
)
|
|
(176,290
|
)
|
||
Total stockholders’ equity
|
9,963
|
|
|
3,928
|
|
||
Total liabilities and stockholders’ equity
|
$
|
13,330
|
|
|
$
|
16,500
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
September 30,
|
|
September 30,
|
||||||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
Revenue
|
$
|
3,481
|
|
|
$
|
4,344
|
|
|
$
|
11,417
|
|
|
$
|
14,950
|
|
Operating expenses:
|
|
|
|
|
|
|
|
||||||||
Cost of revenue (exclusive of depreciation and amortization)
|
1,988
|
|
|
2,609
|
|
|
6,697
|
|
|
9,187
|
|
||||
Research and development
|
296
|
|
|
229
|
|
|
875
|
|
|
817
|
|
||||
Sales and marketing
|
69
|
|
|
70
|
|
|
369
|
|
|
576
|
|
||||
General and administrative
|
970
|
|
|
1,664
|
|
|
2,843
|
|
|
4,009
|
|
||||
Impairment charges
|
1,707
|
|
|
605
|
|
|
1,712
|
|
|
630
|
|
||||
Depreciation and amortization
|
451
|
|
|
455
|
|
|
1,370
|
|
|
1,509
|
|
||||
Total operating expenses
|
5,481
|
|
|
5,632
|
|
|
13,866
|
|
|
16,728
|
|
||||
Loss from operations
|
(2,000
|
)
|
|
(1,288
|
)
|
|
(2,449
|
)
|
|
(1,778
|
)
|
||||
Interest expense and other, net
|
(197
|
)
|
|
(362
|
)
|
|
(916
|
)
|
|
(1,081
|
)
|
||||
Gain on extinguishment of debt
|
9,045
|
|
|
—
|
|
|
9,045
|
|
|
—
|
|
||||
Amortization of debt discount
|
(28
|
)
|
|
(18
|
)
|
|
(64
|
)
|
|
(54
|
)
|
||||
Interest and other income (expense), net
|
8,820
|
|
|
(380
|
)
|
|
8,065
|
|
|
(1,135
|
)
|
||||
Income (loss) before income taxes
|
6,820
|
|
|
(1,668
|
)
|
|
5,616
|
|
|
(2,913
|
)
|
||||
Income tax benefit (expense)
|
284
|
|
|
(37
|
)
|
|
230
|
|
|
(108
|
)
|
||||
Net income (loss)
|
7,104
|
|
|
(1,705
|
)
|
|
5,846
|
|
|
(3,021
|
)
|
||||
Preferred stock dividends
|
3
|
|
|
3
|
|
|
9
|
|
|
9
|
|
||||
Net income (loss) attributable to common stockholders
|
$
|
7,101
|
|
|
$
|
(1,708
|
)
|
|
$
|
5,837
|
|
|
$
|
(3,030
|
)
|
|
|
|
|
|
|
|
|
||||||||
Net income (loss) attributable to common stockholders per share:
|
|
|
|
|
|
|
|
||||||||
Basic net income (loss) per share
|
$
|
0.19
|
|
|
$
|
(0.05
|
)
|
|
$
|
0.16
|
|
|
$
|
(0.09
|
)
|
Diluted net income (loss) per share
|
$
|
0.19
|
|
|
$
|
(0.05
|
)
|
|
$
|
0.15
|
|
|
$
|
(0.09
|
)
|
|
|
|
|
|
|
|
|
||||||||
Weighted-average number of shares of common stock:
|
|
|
|
|
|
|
|
||||||||
Basic
|
36,897
|
|
|
35,492
|
|
|
37,078
|
|
|
35,480
|
|
||||
Diluted
|
37,897
|
|
|
35,492
|
|
|
38,078
|
|
|
35,480
|
|
|
Series A-2 Preferred Stock
|
|
Common Stock
|
|
Treasury Stock
|
|
Additional Paid-In Capital
|
|
Accumulated Deficit
|
|
|
|||||||||||||||||||||
|
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
|
|
|
Total
|
|||||||||||||||||
Balance at December 31, 2016
|
32
|
|
|
$
|
100
|
|
|
36,659
|
|
|
$
|
4
|
|
|
204
|
|
|
$
|
(219
|
)
|
|
$
|
180,333
|
|
|
$
|
(176,290
|
)
|
|
$
|
3,928
|
|
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
5,846
|
|
|
5,846
|
|
||||||
Stock-based compensation
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
377
|
|
|
—
|
|
|
377
|
|
||||||
Issuance of stock on vested restricted stock units
|
—
|
|
|
—
|
|
|
123
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Preferred stock dividends
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(9
|
)
|
|
—
|
|
|
(9
|
)
|
||||||
Issuance of shares from treasury
|
|
|
|
|
|
|
|
|
|
|
|
|
(7,307
|
)
|
|
2,191
|
|
|
(45
|
)
|
|
|
|
|
2,146
|
|
||||||
Purchase of treasury stock
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
7,755
|
|
|
(2,325
|
)
|
|
—
|
|
|
—
|
|
|
(2,325
|
)
|
||||||
Balance at September 30, 2017
|
32
|
|
|
$
|
100
|
|
|
36,782
|
|
|
$
|
4
|
|
|
652
|
|
|
$
|
(353
|
)
|
|
$
|
180,656
|
|
|
$
|
(170,444
|
)
|
|
$
|
9,963
|
|
|
Nine Months Ended September 30,
|
||||||
|
2017
|
|
2016
|
||||
Cash flows from operating activities:
|
|
|
|
||||
Net income (loss)
|
$
|
5,846
|
|
|
$
|
(3,021
|
)
|
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
|
|
|
|
||||
Depreciation and amortization
|
1,370
|
|
|
1,509
|
|
||
Bad debt expense (recovery)
|
(8
|
)
|
|
6
|
|
||
Amortization of debt discount
|
64
|
|
|
54
|
|
||
Non-cash interest expense
|
213
|
|
|
—
|
|
||
Stock-based compensation expense
|
377
|
|
|
748
|
|
||
Gain on debt extinguishment
|
(9,045
|
)
|
|
—
|
|
||
Accrued non-cash stock-based expense
|
—
|
|
|
168
|
|
||
Impairment charges
|
1,712
|
|
|
630
|
|
||
Deferred tax provision (benefit)
|
(230
|
)
|
|
111
|
|
||
Changes in assets and liabilities:
|
|
|
|
||||
Accounts receivable
|
276
|
|
|
953
|
|
||
Prepaid expenses and other current assets
|
211
|
|
|
(342
|
)
|
||
Other assets
|
—
|
|
|
1
|
|
||
Accounts payable
|
126
|
|
|
(271
|
)
|
||
Accrued expenses and other liabilities
|
246
|
|
|
(281
|
)
|
||
Accrued sales taxes and regulatory fees
|
(85
|
)
|
|
—
|
|
||
Net cash provided by operating activities
|
1,073
|
|
|
265
|
|
||
Cash flows from investing activities:
|
|
|
|
||||
Purchases of property and equipment
|
(93
|
)
|
|
(273
|
)
|
||
Net cash used in investing activities
|
(93
|
)
|
|
(273
|
)
|
||
Cash flows from financing activities:
|
|
|
|
||||
Principal payments under borrowing arrangements
|
(341
|
)
|
|
(400
|
)
|
||
Proceeds from new loan agreements, net of expenses of $170
|
2,030
|
|
|
—
|
|
||
Payment of equity issuance costs
|
(45
|
)
|
|
—
|
|
||
Purchase of treasury stock
|
(2,325
|
)
|
|
(13
|
)
|
||
Net cash used in financing activities
|
(681
|
)
|
|
(413
|
)
|
||
Increase (decrease) in cash and cash equivalents
|
299
|
|
|
(421
|
)
|
||
Cash at beginning of period
|
1,140
|
|
|
1,764
|
|
||
Cash at end of period
|
$
|
1,439
|
|
|
$
|
1,343
|
|
|
|
|
|
||||
Supplemental disclosures of cash flow information:
|
|
|
|
||||
Cash paid during the period for interest
|
$
|
777
|
|
|
$
|
841
|
|
|
|
|
|
||||
Non-cash investing and financing activities:
|
|
|
|
||||
Accrued preferred stock dividends
|
$
|
9
|
|
|
$
|
9
|
|
Retired debt and accrued interest obligations in exchange for treasury stock
|
$
|
2,191
|
|
|
$
|
—
|
|
Recognition of prepaid equity issuance costs as additional paid-in capital
|
$
|
—
|
|
|
$
|
18
|
|
|
September 30, 2017
|
|
December 31, 2016
|
||||
Accrued interest
|
$
|
19
|
|
|
$
|
658
|
|
Accrued compensation
|
285
|
|
|
133
|
|
||
Deferred rent expense
|
52
|
|
|
—
|
|
||
Other accrued expenses
|
490
|
|
|
374
|
|
||
Accrued expenses and other liabilities
|
$
|
846
|
|
|
$
|
1,165
|
|
|
September 30, 2017
|
|
December 31, 2016
|
||||
Main Street Term Loan
|
$
|
—
|
|
|
$
|
9,000
|
|
SRS Note
|
—
|
|
|
1,785
|
|
||
Western Alliance Bank A/R Revolver
|
1,000
|
|
|
—
|
|
||
Super G Loan
|
1,096
|
|
|
—
|
|
||
Unamortized debt discounts
|
(308
|
)
|
|
(125
|
)
|
||
Net carrying value
|
1,788
|
|
|
10,660
|
|
||
Less: current maturities
|
(1,298
|
)
|
|
(10,660
|
)
|
||
Long-term obligations, net of debt discount
|
$
|
490
|
|
|
$
|
—
|
|
Outstanding Shares of Common Stock on July 31, 2017 prior to the Debt Recapitalization
|
36,534,840
|
|
Shares of common stock purchased in connection with the Main Street Payoff
|
(7,711,517
|
)
|
Shares of common stock issued in connection with the SRS Note Exchange
|
7,306,930
|
|
Outstanding Shares of Common Stock on July 31, 2017 after the Debt Recapitalization
|
36,130,253
|
|
•
|
On July 31, 2017, the Company and Main Street entered into (i) a payoff letter (the “Main Street Payoff Letter”) that terminated the
$9,000,000
Main Street Term Loan and (ii) a Redemption Agreement (“the Main Street Redemption Agreement”) whereby the Company purchased
7,711,517
shares of the Company’s common stock held by Main Street, in exchange for total cash payments from the Company of
$2,550,000
(together the “Main Street Payoff”). On July 31, 2017, the Company funded the Main Street Payoff using
$350,000
of the Company’s existing cash plus cash proceeds of
$2,200,000
borrowed under loan agreements with Western Alliance Bank and Super G (each defined below).
|
•
|
On July 31, 2017, the Company and SRS entered into a Note Exchange Agreement (the “SRS Note Exchange Agreement’) to extinguish the
$2,562,000
of obligations on the SRS Note (including accrued interest for July 2017 of
$32,000
) in exchange for
7,306,930
shares of the Company’s common stock (the “SRS Note Exchange”). Our President, Chief Executive Officer, and Director, Peter Holst, held a
27.3%
interest in the SRS Note (or
$699,528
as of July 31, 2017 including accrued interest) and received
1,806,087
shares of the Company’s common stock in connection with the SRS Note Exchange (representing
|
Year Ending December 31,
|
Western Alliance Bank
|
Super G
|
Total
|
||||||
Remaining 2017
|
$
|
200
|
|
$
|
64
|
|
$
|
264
|
|
2018
|
400
|
|
570
|
|
970
|
|
|||
Seven months ended July 31, 2019
|
400
|
|
462
|
|
862
|
|
|||
|
$
|
1,000
|
|
$
|
1,096
|
|
$
|
2,096
|
|
|
Outstanding
|
|
Exercisable
|
||||||||||
|
Number of Shares Underlying Options
|
|
Weighted
Average Exercise Price |
|
Number of Shares Underlying Options
|
|
Weighted
Average Exercise Price |
||||||
Options outstanding, December 31, 2016
|
1,222
|
|
|
$
|
1.99
|
|
|
1,198
|
|
|
$
|
1.99
|
|
Granted
|
—
|
|
|
—
|
|
|
|
|
|
||||
Exercised
|
—
|
|
|
—
|
|
|
|
|
|
||||
Expired
|
(10
|
)
|
|
2.37
|
|
|
|
|
|
||||
Forfeited
|
(6
|
)
|
|
1.93
|
|
|
|
|
|
||||
Options outstanding, September 30, 2017
|
1,206
|
|
|
$
|
1.99
|
|
|
1,206
|
|
|
$
|
1.99
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
September 30,
|
|
September 30,
|
||||||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
General and administrative
|
$
|
—
|
|
|
$
|
89
|
|
|
$
|
18
|
|
|
$
|
272
|
|
|
Restricted Shares
|
|
Weighted Average
Grant Price |
|||
Unvested restricted shares outstanding, December 31, 2016
|
363
|
|
|
$
|
1.08
|
|
Granted
|
—
|
|
|
—
|
|
|
Vested
|
(9
|
)
|
|
1.47
|
|
|
Forfeited
|
—
|
|
|
—
|
|
|
Unvested restricted shares outstanding, September 30, 2017
|
354
|
|
|
$
|
1.07
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
September 30,
|
|
September 30,
|
||||||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
Cost of revenue
|
$
|
2
|
|
|
$
|
2
|
|
|
$
|
5
|
|
|
$
|
5
|
|
Research and development
|
1
|
|
|
1
|
|
|
4
|
|
|
4
|
|
||||
General and administrative
|
12
|
|
|
24
|
|
|
36
|
|
|
165
|
|
||||
|
$
|
15
|
|
|
$
|
27
|
|
|
$
|
45
|
|
|
$
|
174
|
|
|
RSUs
|
|
Weighted Average
Grant Price |
|||
Unvested RSUs outstanding, December 31, 2016
|
3,196
|
|
|
$
|
0.62
|
|
Granted
|
—
|
|
|
—
|
|
|
Vested
|
(724
|
)
|
|
0.42
|
|
|
Forfeited
|
(85
|
)
|
|
0.61
|
|
|
Unvested RSUs outstanding, September 30, 2017
|
2,387
|
|
|
$
|
0.68
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
September 30,
|
|
September 30,
|
||||||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
Cost of revenue
|
$
|
10
|
|
|
$
|
9
|
|
|
$
|
29
|
|
|
$
|
26
|
|
Research and development
|
14
|
|
|
10
|
|
|
43
|
|
|
29
|
|
||||
Sales and marketing
|
2
|
|
|
3
|
|
|
6
|
|
|
4
|
|
||||
General and administrative
|
55
|
|
|
82
|
|
|
236
|
|
|
243
|
|
||||
|
$
|
81
|
|
|
$
|
104
|
|
|
$
|
314
|
|
|
$
|
302
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
Numerator:
|
|
|
|
|
|
|
|
||||||||
Net income (loss)
|
$
|
7,104
|
|
|
$
|
(1,705
|
)
|
|
$
|
5,846
|
|
|
$
|
(3,021
|
)
|
Less: preferred stock dividends
|
3
|
|
|
3
|
|
|
9
|
|
|
9
|
|
||||
Net income (loss) attributable to common stockholders
|
$
|
7,101
|
|
|
$
|
(1,708
|
)
|
|
$
|
5,837
|
|
|
$
|
(3,030
|
)
|
Denominator:
|
|
|
|
|
|
|
|
||||||||
Weighted-average shares outstanding - basic
|
36,897
|
|
|
35,492
|
|
|
37,078
|
|
|
35,480
|
|
||||
Add effect of dilutive securities:
|
|
|
|
|
|
|
|
||||||||
Unvested restricted stock units
|
672
|
|
|
—
|
|
|
672
|
|
|
—
|
|
||||
Stock options outstanding
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Unvested restricted stock
|
249
|
|
|
—
|
|
|
249
|
|
|
—
|
|
||||
Shares of common stock issuable upon conversion
of preferred stock |
79
|
|
|
—
|
|
|
79
|
|
|
—
|
|
||||
Weighted-average shares outstanding - diluted
|
37,897
|
|
|
35,492
|
|
|
38,078
|
|
|
35,480
|
|
||||
Basic net income (loss) per share
|
$
|
0.19
|
|
|
$
|
(0.05
|
)
|
|
$
|
0.16
|
|
|
$
|
(0.09
|
)
|
Diluted net income (loss) per share
|
$
|
0.19
|
|
|
$
|
(0.05
|
)
|
|
$
|
0.15
|
|
|
$
|
(0.09
|
)
|
|
Three and Nine Months Ended September 30,
|
||||
|
2017
|
|
2016
|
||
Unvested restricted stock units
|
1,715
|
|
|
3,208
|
|
Unvested restricted stock awards
|
105
|
|
|
363
|
|
Outstanding stock options
|
1,206
|
|
|
1,222
|
|
Shares of common stock issuable upon conversion of preferred stock, Series A-2
|
—
|
|
|
79
|
|
Warrants
|
550
|
|
|
—
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
Domestic
|
$
|
2,408
|
|
|
$
|
3,158
|
|
|
$
|
8,059
|
|
|
$
|
10,971
|
|
Foreign
|
1,073
|
|
|
1,186
|
|
|
3,358
|
|
|
3,979
|
|
||||
Total Revenue
|
$
|
3,481
|
|
|
$
|
4,344
|
|
|
$
|
11,417
|
|
|
$
|
14,950
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
September 30,
|
|
September 30,
|
||||||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
Revenue
|
|
|
|
|
|
|
|
||||||||
Video collaboration services
|
$
|
2,085
|
|
|
$
|
2,494
|
|
|
$
|
6,876
|
|
|
$
|
8,403
|
|
Network services
|
1,325
|
|
|
1,805
|
|
|
4,288
|
|
|
6,168
|
|
||||
Professional and other services
|
71
|
|
|
45
|
|
|
253
|
|
|
379
|
|
||||
Total revenue
|
$
|
3,481
|
|
|
$
|
4,344
|
|
|
$
|
11,417
|
|
|
$
|
14,950
|
|
Exhibit
Number
|
|
Description
|
|
||
|
||
|
||
|
||
101.INS
|
|
XBRL Instance Document
|
101.SCH
|
|
XBRL Taxonomy Extension Schema
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase
|
|
GLOWPOINT, INC.
|
|
|
|
|
11/14/2017
|
By:
|
/s/ Peter Holst
|
|
|
Peter Holst
|
|
|
Chief Executive Officer
|
|
|
(Principal Executive Officer)
|
11/14/2017
|
By:
|
/s/ David Clark
|
|
|
David Clark
|
|
|
Chief Financial Officer
|
|
|
(Principal Financial and Accounting Officer)
|
1.
|
I have reviewed this quarterly report on Form 10-Q of Glowpoint, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.
|
5.
|
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
1.
|
I have reviewed this quarterly report on Form 10-Q of Glowpoint, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.
|
5.
|
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
1.
|
The accompanying Quarterly Report on Form 10-Q of the Company for the quarter ended
September 30, 2017
(the "Report") fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
|
2.
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|